Ads
related to: pharma
Search results
Nxera Pharma (OTCMKTS:SOLTF) Stock Price Passes Below Two Hundred Day Moving Average of $9.89
ETF DAILY NEWS· 14 hours agoNxera Pharma Co., Ltd. (OTCMKTS:SOLTF – Get Free Report)’s share price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred ...
Inozyme Pharma stock rated Overweight by Wells Fargo, highlighting rare disease focus By...
Investing.com· 10 hours agoOn Thursday, Wells Fargo (NYSE:WFC) initiated coverage on Inozyme Pharma Inc. (NASDAQ:INZY) stock,...
FSD Pharma, Inc. Wins Petition to Confirm Arbitration Awards Entered Against Dr. Raza Bokhari...
The Joplin Globe· 7 hours agoTORONTO, ON / ACCESSWIRE / May 31, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building ...
Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
Zacks via Yahoo Finance· 5 hours agoJ&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority...
Pfizer says its its lung cancer drug Lorbrena could be a $1 billion blockbuster
Quartz· 3 hours agoPharma giant Pfizer said that its lung cancer drug Lorbrena could reach blockbuster status by 2030...
Pharma Billionaire's Fortune More Than Doubles In A Day On Cancer Drug Trial News
Forbes· 19 hours agoShares of biotech firm Summit Therapeutics more than tripled on Thursday following good news about a...
French pharma Sanofi announces stock purchase plan for employees
dpa international via Yahoo Finance· 4 hours agoFrench pharmaceutical firm Sanofi has announced its stock purchase plan for employees for this year....
Pharmaceutical Giant Cencora Confirms Patient Data Breach Impacting over a Dozen Pharma Companies -...
CPO Magazine· 7 hours agoU.S. pharmaceutical giant Cencora has disclosed that the February 2024 data breach leaked sensitive...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 hours agoBut as society learned to live with Covid — and other concerns around the economy and politics took...
Aurobindo Pharma Outperforms Expectations with Strong Q4, Eyes Robust Growth Ahead By Investing.com
Investing.com· 4 days agoAurobindo Pharma (NS:ARBN) has outperformed expectations in the fourth quarter of FY24, with both...
Ad
related to: pharma